ELife

This article may have too many red links. You can help Wikipedia by writing articles to help lower the number of red links. (September 2018)

eLife is a scientific journal for the biomedical and life sciences. It is open access. It was established at the end of 2012 by the Howard Hughes Medical Institute, Max Planck Society, and Wellcome Trust. These organizations gave the money for the journal's business and publishing operations.^[1]

The editor-in-chief is Randy Schekman (University of California, Berkeley).^[2] Editorial decisions are made largely by senior editors and members of the board of reviewing editors. These are all people who work as scientists. They are in many fields, including human genetics, neuroscience, biophysics, and epidemiology.^[3] eLife used to be a normal peer-reviewed journal. In 2021, it stopped using the peer review process that most journals use.^[4] At present, it will publish all articles that are reviewed, and not reject any.^[5]

1. ↑ Matt McGrath (10 April 2012), Trust pushes for open access to research, BBC
2. ↑ Freya Boardman-Pretty (5 November 2011), "Open-access science journal leaves editing to the experts", Times Higher Education
3. ↑ Communicating the latest advances in life science and biomedicine, eLife, retrieved 6 October 2015
4. ↑ Eisen, Michael B; Akhmanova, Anna; Behrens, Timothy E; Harper, Diane M; Weigel, Detlef; Zaidi, Mone (December 1, 2020). "Implementing a "publish, then review" model of publishing". eLife. 9: e64910. doi:10.7554/eLife.64910. PMC 7710353. PMID 33258772.
5. ↑ Kincaid, Ellie (24 October 2024). "eLife latest in string of major journals put on hold from Web of Science". Retraction Watch.